ROUNDTABLE CDMO Selection: Critical Considerations That Can Make or Break your CGT Development
Thursday, June 1, 2023 09:15 AM - 10:15 AM
Salle Maillot
Roundtable
Moderator
William (Bill) Milligan, BSc, Senior Vice President of Corporate & Business Development, Steminent Biotherapeutics, Canada
Co-Moderator
Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Panelists
Behnam Ahmadian Baghbaderani, PhD, Executive Director, Global Head of Process Development, Lonza Cell and Gene Technologies, Lonza
Mitchel Sivilotti, MSc, Chief Executive Officer, OmniaBio
John Lee, PhD, Head of Cell Therapy, Center for Breakthrough Medicines
Peter Jaehn, PhD, Senior Account Director, Cell and Gene Therapy, Catalent Cell & Gene Therapy, Germany
William (Bill) Milligan, BSc, Senior Vice President of Corporate & Business Development, Steminent Biotherapeutics, Canada
Co-Moderator
Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Panelists
Behnam Ahmadian Baghbaderani, PhD, Executive Director, Global Head of Process Development, Lonza Cell and Gene Technologies, Lonza
Mitchel Sivilotti, MSc, Chief Executive Officer, OmniaBio
John Lee, PhD, Head of Cell Therapy, Center for Breakthrough Medicines
Peter Jaehn, PhD, Senior Account Director, Cell and Gene Therapy, Catalent Cell & Gene Therapy, Germany
SPONSORED BY:
SPONSORED BY:
Bruce Levine PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Co-moderator
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Co-moderator
William (Bill) Milligan
Senior Vice President of Corporate & Business Development
Steminent Biotherapeutics
Moderator
Senior Vice President of Corporate & Business Development
Steminent Biotherapeutics
Moderator
Behnam Ahmadian Baghbaderani
Executive Director, Global Head of Process Development, Lonza Cell and Gene Technologies
Lonza
Panelist
Executive Director, Global Head of Process Development, Lonza Cell and Gene Technologies
Lonza
Panelist
